Syndax Pharmaceuticals

SNDXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.822 B

$20.40 +3.24%

Close of 7 Aug 2026

Revenue

$172.4M

#2349 by revenue

Earnings

-$285.4M

Loss-making

Shares outstanding

89,297,086

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#120Damora TherapeuticsDMRA$1.84B
#121Generate BiomedicinesGENB$1.84B
#122Syndax PharmaceuticalsSNDX$1.82B
#123KardiganKARD$1.80B
#124PERRIGOPRGO$1.78B

Where these numbers come from

Share counts and financials for Syndax Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.